West Nile virus breaks out in Texas; PATH Malaria Vaccine Initiative names scientists to advisory council;

> PATH Malaria Vaccine Initiative named malaria scientists and vaccinologists to its advisory council. Release

> The New Jersey Supreme Court halted a lawsuit filed by a man claiming that a polio vaccine he received in the 1970s caused a brain tumor. Story

> FDA cleared the Infectious Disease Research Institute and Medicago to initiate a Phase I clinical trial for an H5N1 avian influenza VLP vaccine candidate. Release

> Genocea Biosciences initiated a Phase I/IIa clinical study with its lead investigational herpes vaccine candidate, GEN-003. Release

> Novavax and PATH teamed up to develop Novavax's RSV vaccine to protect infants through maternal immunization in low-resource countries. Article

And Finally... Nine people in Dallas County, TX, have died from a West Nile virus outbreak that infected 175 people. News

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.